THC
Tenet Health
Data as of 2026-09-05
Company attributes
Price
Interactive 5-year price history chart for THC. Latest close $263.49.
Pillar breakdown
0–100 percentile rank against the current universe (sector-relative for Quality / Value / Growth / Profitability)
- QualityProfit margins & asset efficiency83ExceptionalHealth Care median (n=163) 51
- ValuePrice vs fundamentals83ExceptionalHealth Care median (n=163) 51
- GrowthRevenue & earnings trajectory79ExceptionalHealth Care median (n=163) 50
- MomentumRecent price strength71ExceptionalHealth Care median (n=163) 62
- HealthBalance sheet & solvency43AverageHealth Care median (n=163) 56
- ProfitabilityROE, ROA, ROIC66StrongHealth Care median (n=163) 49
- TechnicalTrend & volatility signals62StrongHealth Care median (n=163) 62
- RiskVolatility & drawdown profile62StrongHealth Care median (n=163) 47
Pillars not shown: Sentiment, ML (Phase 5+).
Risk Summary
Low- Insider sell cluster (Cohen-Malloy-Pomorski 2012)[insider_sell_cluster]
Rolls up Phase 4.5 earnings-manipulation defenses (Sloan · Beneish · Dechow · REM · restatement · late-filing · earnings- quality time-series) into a single 0-100 risk index. The soft composite penalty (max 10 pts) is informational only — the ranking uses the raw composite score per project Rule 16.
Fair price check
4 different valuation methods each estimate what THC should be worth, then we compare to today's price.
- EV/EBITDAUndervaluedthinks it's a bargain — estimates $1204.51, about 357% above today
- P/E multiplesUndervaluedthinks it's a bargain — estimates $830.95, about 215% above today
- P/B multiplesOvervaluedthinks it's expensive — estimates $157.89, about 40% below today
- DCF (2-stage)Overvaluedthinks it's expensive — estimates $153.40, about 42% below today
How to read this: “Cheap” = method's fair price is at least 20% above today. “Fair” = within ±10–20%. “Pricey” = at least 10% below today. Outliers (values more than 5× or less than 0.2× today's price) are excluded.
Fair price ensemble
- Median fair
- $494.42
- Margin of safety(vs fair value)
- +46.7%
- Max (ex-outliers)
- $1204.51
- Tangible BVPS
- —
- Insider-sell cluster
Median of all applicable methods (current price $263.49). Per-method estimates + each method’s cheap/fair/pricey read are in the Fair price check above. Outliers above 5× or below 0.2× current price are excluded from the max but kept in the median. See methodology for the 6-method ensemble + 7 defenses.
Defense layer. Flags mark elevated risk, never confirmed fraud. This model cannot catch every manipulation and decays after publication — weigh it against its stated error rates.
Supporting dataRaw fundamentals & data-quality provenance behind the scores above
Raw fundamentals (SEC EDGAR)
| Metric | Value |
|---|---|
| Market cap | $21.22B |
| Revenue (TTM) | $21.81B |
| Net income (TTM) | $3.17B |
| Operating cash flow (TTM) | $4.01B |
| CapEx (TTM) | $992.00M |
| Free cash flow (TTM)CFO − CapEx | $3.02B |
| Total assets | $30.68B |
| Total liabilities | $21.98B |
| Stockholders' equity | $4.66B |
| Cash & equivalents | $2.17B |
| Shares outstanding | 80.52M |
| EPS (basic) | $39.42 |
| EPS (diluted) | $39.42 |
| P/E ratio (TTM) | 6.68 |
TTM = trailing twelve months. Balance sheet items are point-in-time (latest filing).
Data quality
- Latest filed date
- 2026-07-29
- Latest period end
- 2026-07-24
- Filing lag
- 38 days
- Missing metrics
- 5(gross_profit, cost_of_revenue, research_and_development, sga_expense, dividends_paid)
Composite is the 8-pillar weighted score over quality, value, growth, momentum, health, profitability, technical, and risk. Sentiment + ML pillars are reserved for a later phase; until then their weight redistributes pro-rata. Fair price is the median of 6 valuation methods (Graham, P/E / P/B / EV-EBITDA multiples, RIM, DCF) with outliers above 5× current price excluded from the max. Risk-overlay flags annotate only — they suppress the entered-top-5 badge but do not modify the composite.